Phenylketonuria: Sapropterin
(asked on 10th March 2021) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of NICE draft guidance on using Sapropterin for treating phenylketonuria, published on 25 February; and what plans they have to meet with the authors of that guidance.
This question was answered on 17th March 2021
The National Institute for Health and Care Excellence is an independent body and is responsible for assessing new medicines and treatments in accordance with its existing methods and processes. It would not be appropriate for Ministers to intervene in the development of their recommendations.